Literature DB >> 20332535

Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.

Yongjun Wang1, Laura A Solt, Thomas P Burris.   

Abstract

Fibroblast growth factor 21 (FGF21) is a hormone produced by fat and the liver that plays an important role in lipid metabolism. FGF21 expression is induced by peroxisome proliferator-actived receptor alpha in response to physiological conditions requiring increased fatty acid oxidation. Retinoic acid receptor-related receptor alpha (RORalpha) is another nuclear receptor that plays a critical role in lipid metabolism as well as in regulation of the circadian rhythm. In this study we demonstrate that RORalpha directly regulates the expression and secretion of FGF21. A canonical ROR response element was identified in the proximal promoter of the FGF21 gene and shown to exhibit functional activity. Overexpression of RORalpha in HepG2 cells resulted in increased expression and secretion of FGF21. Suppression of RORalpha expression caused a decrease in FGF21 expression and secretion, suggesting that RORalpha contributes to the basal expression of FGF21. These data suggest that one mechanism by which RORalpha regulates lipid metabolism may be by modulation of FGF21 secretion. Furthermore, this study identifies a clear link between RORalpha, a key regulator of the mammalian clock, and FGF21, an important hormone regulating glucose and lipid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332535      PMCID: PMC2871432          DOI: 10.1074/jbc.M110.102160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Adverse metabolic and cardiovascular consequences of circadian misalignment.

Authors:  Frank A J L Scheer; Michael F Hilton; Christos S Mantzoros; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 2.  FGF21: a novel prospect for the treatment of metabolic diseases.

Authors:  Alexei Kharitonenkov; Armen B Shanafelt
Journal:  Curr Opin Investig Drugs       Date:  2009-04

3.  FGF-21 as a novel metabolic regulator.

Authors:  Alexei Kharitonenkov; Tatiyana L Shiyanova; Anja Koester; Amy M Ford; Radmila Micanovic; Elizabeth J Galbreath; George E Sandusky; Lisa J Hammond; Julie S Moyers; Rebecca A Owens; Jesper Gromada; Joseph T Brozinick; Eric D Hawkins; Victor J Wroblewski; De-Shan Li; Farrokh Mehrbod; S Richard Jaskunas; Armen B Shanafelt
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

4.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Authors:  Cecilia Gälman; Tomas Lundåsen; Alexei Kharitonenkov; Holly A Bina; Mats Eriksson; Ingiäld Hafström; Maria Dahlin; Per Amark; Bo Angelin; Mats Rudling
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

5.  Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.

Authors:  Katsutaka Oishi; Daisuke Uchida; Norio Ishida
Journal:  FEBS Lett       Date:  2008-10-07       Impact factor: 4.124

6.  Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.

Authors:  Atul R Chopra; Jean-Francois Louet; Pradip Saha; Jie An; Franco Demayo; Jianming Xu; Brian York; Saul Karpen; Milton Finegold; David Moore; Lawrence Chan; Christopher B Newgard; Bert W O'Malley
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

7.  Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Authors:  Alberto O Chavez; Marjorie Molina-Carrion; Muhammad A Abdul-Ghani; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

8.  Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

Authors:  Knut Mai; Janin Andres; Katrin Biedasek; Jessica Weicht; Thomas Bobbert; Markus Sabath; Sabine Meinus; Franziska Reinecke; Matthias Möhlig; Martin O Weickert; Markus Clemenz; Andreas F H Pfeiffer; Ulrich Kintscher; Simone Spuler; Joachim Spranger
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

Review 9.  Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.

Authors:  Anton M Jetten
Journal:  Nucl Recept Signal       Date:  2009-04-03

10.  Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.

Authors:  Jing Xu; David J Lloyd; Clarence Hale; Shanaka Stanislaus; Michelle Chen; Glenn Sivits; Steven Vonderfecht; Randy Hecht; Yue-Sheng Li; Richard A Lindberg; Jin-Long Chen; Dae Young Jung; Zhiyou Zhang; Hwi-Jin Ko; Jason K Kim; Murielle M Véniant
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

View more
  48 in total

1.  Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

Authors:  Yongjun Wang; Naresh Kumar; Philippe Nuhant; Michael D Cameron; Monica A Istrate; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-11-19       Impact factor: 5.100

2.  No time to lose: workshop on circadian rhythms and metabolic disease.

Authors:  Corinne M Silva; Sheryl Sato; Ronald N Margolis
Journal:  Genes Dev       Date:  2010-07-15       Impact factor: 11.361

3.  Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.

Authors:  Naresh Kumar; Douglas J Kojetin; Laura A Solt; K Ganesh Kumar; Philippe Nuhant; Derek R Duckett; Michael D Cameron; Andrew A Butler; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-12-06       Impact factor: 5.100

4.  Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

Authors:  Prasant Kumar Jena; Lili Sheng; Jacopo Di Lucente; Lee-Way Jin; Izumi Maezawa; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

5.  Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice.

Authors:  Yu Li; Kimberly Wong; Kenneth Walsh; Bin Gao; Mengwei Zang
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

6.  Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.

Authors:  Eleni M Domouzoglou; Eleftheria Maratos-Flier
Journal:  Am J Clin Nutr       Date:  2011-02-23       Impact factor: 7.045

7.  TCF4/β-catenin complex is directly upstream of FGF21 in mouse stomach cancer cells.

Authors:  Jihua Pei; Na Song; Limin Wu; Jinbo Qi; Shenglong Xia; Changlong Xu; Bo Zheng; Jun Yang; Yanyan Qiu; Haijun Wang; Yi Jiang
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

Review 8.  REV-ERB and ROR nuclear receptors as drug targets.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

9.  Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.

Authors:  Amena Archer; Nicolas Venteclef; Agneta Mode; Matteo Pedrelli; Chiara Gabbi; Karine Clément; Paolo Parini; Jan-Åke Gustafsson; Marion Korach-André
Journal:  Mol Endocrinol       Date:  2012-10-16

10.  Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.

Authors:  Xin Tong; Deqiang Zhang; Katie Buelow; Anirvan Guha; Blake Arthurs; Hugh J M Brady; Lei Yin
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.